# University of California Irvine Medical Center Campus Donor Center – FDA Inspection, May 15, 2024

Source: https://www.keypedia.com/records/fda_inspections/university-of-california-irvine-medical-center-campus-donor-center/832724cf-688b-46f2-866b-5978bbd0ae33
Source feed: FDA_Inspections

> FDA inspection 1238620 of University of California Irvine Medical Center Campus Donor Center, May 15, 2024. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR parts 606 and 630. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1238620
- Company Name: University of California Irvine Medical Center Campus Donor Center
- Inspection Date: 2024-05-15
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 3

## Related Documents

- FDA Inspection 1115738 - 2019-12-11
- FDA Inspection 1025925 - 2017-09-14
- FDA Inspection 944046 - 2015-09-29
- FDA Inspection 866407 - 2014-02-13

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/emily-b-camire/dff5f4c6-bcbe-4ef1-ac0b-1b2701b311ef)
- [FDA Personnel](https://www.keypedia.com/people/maurine-fadlalla/519e6e71-a50a-43b5-b41a-2249ec9afdd5)

Company: https://www.keypedia.com/companies/university-of-california-irvine-medical-center-campus-donor-center/ab5fd5bc-26c8-44ed-b9c0-3ed45621bb5b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
